EurekaMag.com logo
+ Translate

Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I


, : Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. Endocrinology 129(3): 1201-1206

The insulin-like growth factors (IGFs) are present in extracellular fluids bound to specific, high affinity IGF binding proteins (IGFBPs). IGFBPs are believed to mediate IGF transport to tissues and to modulate their actions on target cells. To determine whether IGF-I can modulate IGFBP concentrations in blood and to distinguish the effects of IGF-I from those of somatotropin (GH), serum IGFBP concentration was assessed in 4 genotypically distinct groups of sibling transgenic mice that differed in respect to their expression of IGF-I and GH. This unique physiological situation was created by crossing IGF-I transgenic mice to GH-deficient, dwarf mice in whom somatotrophs were genetically ablated by the expression of a diphtheria toxin transgene in the somatotrophs. Because both transgenic mouse lines were hemizygous for their respective transgene, progeny of the cross differed genotypically, according to whether or not they carried one or both transgenes, and phenotypically in regard to their relative expression of IGF-I and GH. GH-deficient mice showed a 15.7-fold decrease in serum IGF-I and a 5.5-fold decrease in serum IGFBP-3, but no change in a serum doublet band of 29 000 to 34 000 Mr, as assessed by ligand blotting. When IGF-I was expressed in the GH-deficient mice, serum levels of IGF-I and IGFBP-3 were 69 and 64% of those in normal sera, resp. The 29 000 to 34 000 Mr doublet bands also increased. The ternary 150 kDa IGF-IGFBP complex, however, was not restored, presumably because IGF-I has no influence on the expression of the acid-labile subunit in this complex. In mice with IGF-I overexpression, serum IGFBP-3 was increased 2.1-fold and the sum of the 29 000 to 34 000 doublet bands was increased 2.9-fold. Immunoblotting showed that the changes in the 29 000 to 34 000 Mr forms observed by ligand blotting appeared to be predominantly due to changes in IGFBP-2. The results show that IGF-I can induce IGFBP-3 and IGFBP-2 independently of GH and that IGF-I is a major controller of these binding proteins.

(PDF same-day service: $19.90)

Accession: 002477156

PMID: 1714829

DOI: 10.1210/endo-129-3-1201

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Camacho Hubner C.; Clemmons D.R.; D'ercole A.J., 1991: Regulation of insulin like growth factor igf binding proteins in transgenic mice and with altered expression of growth hormone and igf i. The insulin-like growth factors (IGFs) are present in extracellular fluids bound to specific, high affinity IGF binding proteins (IGFBPs). IGFBPs are believed to mediate IGF transport to tissues and to modulate their actions on target cells. To de...

Blackburn, A.; Dressendorfer, R.A.; Blum, W.F.; Erhard, M.; Brem, G.; Strasburger, C.J.; Wolf, E., 1997: Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice. Hemizygous transgenic mice carrying phosphoenolpyruvate carboxykinase (PEPCK)-IGF-II fusion genes were crossed with hemizygous PEPCK-bovine growth hormone (bGH) transgenic mice. Offspring harbouring both transgenes (IB), the IGF-II transgene (I) o...

Blackburn, A.; Dressendörfer, R.A.; Blum, W.F.; Erhard, M.; Brem, G.; Strasburger, C.J.; Wolf, E., 1998: Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice. To study interactions between insulin-like growth factor-II (IGF-II) and growth hormone (GH) in vivo, we crossed hemizygous transgenic mice carrying phosphoenolpyruvate carboxykinase (PEPCK)-IGF-II fusion genes with hemizygous PEPCK-bovine GH (bGH...

Fielder, P.J.; Guevara-Aguirre, J.; Rosenbloom, A.L.; Carlsson, L.; Hintz, R.L.; Rosenfeld, R.G., 1992: Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients. Recently, an isolated population of apparent GH-receptor deficient (GHRD) patients has been identified in the Loja province of southern Ecuador. These individuals presented many of the physical and biochemical phenotypes characteristic of Laron-Sy...

Fielder P.J.; Guevara Aguirre J.; Rosenbloom A.L.; Carlsson L.; Hintz R.L.; Rosenfeld R.G., 1992: Expression of serum insulin like growth factors insulin like growth factor binding proteins and the growth hormone binding protein in heterozygote relatives of ecuadorian growth hormone receptor deficient patients. Recently, an isolated population of apparent GH-receptor deficient (GHRD) patients has been identified in the Loja province of southern Ecuador. These individuals presented many of the physical and biochemical phenotypes characteristic of Laron-Sy...

Iida, K.; Del Rincon, J.P.; Kim, D-Sun.; Itoh, E.; Nass, R.; Coschigano, K.T.; Kopchick, J.J.; Thorner, M.O., 2004: Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. GH has diverse biological actions that are mediated by binding to a specific, high-affinity cell surface receptor (GHR). Expression of GHR is tissue specific and a requirement for cellular responsiveness to GH. IGF-I is produced in multiple tissue...

IIda, K.; Del Rincon, J.P.; Kim, D.S.n; Itoh, E.; Nass, R.; Coschigano, K.T.; Kopchick, J.J.; Thorner, M.O., 2004: Tissue-specific regulation of growth hormone receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient mice and transgenic mice that overexpress bovine GH or a bGH antagonist. GH has diverse biological actions that are mediated by binding to a specific, high-affinity cell surface receptor (GHR). Expression of GHR is tissue specific and a requirement for cellular responsiveness to GH. IGF-I is produced in multiple tissue...

Carter, A.M.; Kingston, M.J.; Han, K.K.; Mazzuca, D.M.; Nygard, K.; Han, V.K.M., 2000: Altered expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during intrauterine growth restriction in guinea pigs. Placenta 21(7): A 6, September

Hoeflich, A.; Nedbal, S.; Blum, W.F.; Erhard, M.; Lahm, H.; Brem, G.; Kolb, H.J.; Wanke, R.; Wolf, E., 2001: Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. To clarify the role of insulin-like growth factor (IGF)-binding protein-2 (IGFBP-2) in postnatal growth regulation, hemizygous CMV-IGFBP-2 transgenic mice were crossed with hemizygous PEPCK-bGH transgenic mice, which are characterized by serum GH...

Huang, H.; Rajkumar, K.; Murphy, L.J., 1997: Expression of insulin-like growth factor binding proteins (IGFBPs) in IGFBP-1 transgenic mice. The hepatic and renal expressions of the insulin-like growth factor binding proteins (IGFBPs) were examined in transgenic (Tg) mice which overexpress a rat IGFBP-1 transgene driven by the phosphoglycerate kinase-1 promoter. There were no significa...